If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
80.30    -2.80 (-3.37%)
Bid:
80.10
Ask:
81.10
Spread: 1.00 (1.248%)
Market Cap: £131.65m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

Pre-close Trading Update

23 Jun 2009 07:00

RNS Number : 3162U
Yule Catto & Co PLC
23 June 2009
Β 

ο»Ώ

23 JuneΒ 2009

Yule Catto & Co plcΒ 

Pre-closeΒ Trading Update

Yule CattoΒ & Co plc ("Yule Catto" or theΒ "Group"), the international producer of speciality chemicals, today issues a trading update in advance of entering its close period.

The BoardΒ expectsΒ underlyingΒ half yearΒ profit before taxΒ to be ahead of last year.

The Polymers business, following a very slow start to the year, has generally seen volumes circa 15% down on 2008. However, with the benefit of currency movements and management's rigorous focus on cost control, operating profit for the half year will be ahead of 2008.Β 

Pharma Chemicals has seen variableΒ demandΒ during the first half. The benefit of currency and the restructuringΒ of the Group'sΒ Italian plantΒ means that,Β whilstΒ overall volume has been lowerΒ than expected,Β operatingΒ profit willΒ be at a similar level to the first half of 2008.

William BlytheΒ Limited, the Group'sΒ onlyΒ remaining Impact ChemicalsΒ business,Β has seenΒ a reduction inΒ volumes,Β but followingΒ the successful restructuring of this business in the first quarter of last year, operating profit will be ahead atΒ the half year.

The Group remains on track to meet its debt reduction targets.

The overall economicΒ environmentΒ remains difficult. The favourable currency situation has started to reverse to some extent, and oil price risesΒ are likely to make the raw material environment more difficult in Polymers in due course. As such,Β it is difficult to provide guidance for the full year. However, givenΒ management'sΒ tight focus onΒ cost and theΒ goodΒ progress made in the first half,Β theΒ BoardΒ now expectsΒ profit before taxΒ for the full yearΒ to be ahead ofΒ current market expectationsΒ although stillΒ belowΒ that of last year.

Yule CattoΒ expects to announceΒ its 2009 half year results onΒ 24Β August 2009.

Yule Catto reported full year underlying profit before tax for 2008 of Β£32.7M, which excluded the results of the Groups four divested Impact businesses. First half 2008 underlying profit before tax on the same basis was Β£17.4M.

ENQUIRIES:

Yule CattoΒ & Co plc

Tel: 01279 442791

Adrian Whitfield, Chief ExecutiveΒ 

David Blackwood, Finance DirectorΒ 

Β 

Hogarth Partnership Limited

Tel: 020 7357 9477

John Olsen

Andrew Jaques

Ian Payne

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTFTMBTMMBTTIL
Date   Source Headline
26th Jun 20263:53 pmRNSDirector/PDMR Shareholding
22nd Jun 20261:31 pmRNSResults of AGM
22nd Jun 20267:00 amRNSAGM trading statement
19th Jun 20267:00 amRNSDivestment of Acrylate Monomers
1st Jun 20262:42 pmRNSHolding(s) in Company
29th May 20263:57 pmRNSTotal Voting Rights
22nd May 20265:21 pmRNSNotice of AGM
8th May 20264:33 pmRNSAdmission to Trading
7th May 20261:51 pmRNSApplication for Admission to Trading
5th May 20264:25 pmRNSHolding(s) in Company
30th Apr 20264:40 pmRNSAnnual Financial Report
30th Apr 20263:17 pmRNSDirector/PDMR Shareholding
30th Apr 202611:25 amRNSDirector/PDMR Shareholding
30th Apr 20267:01 amRNSChange of Chief Financial Officer
30th Apr 20267:00 amRNSFinal Results
19th Mar 20267:00 amRNSTrading and refinancing update
11th Feb 20261:46 pmRNSStatement re potential refinancing
29th Jan 20267:00 amRNSTrading Statement - Winter 2026
27th Jan 20264:51 pmRNSHolding(s) in Company
26th Jan 20264:23 pmRNSHolding(s) in Company
18th Dec 20257:00 amRNSReceivables purchasing arrangement
12th Dec 20259:30 amRNSDirectorate change
12th Nov 20257:00 amRNSDirector/PDMR Shareholding
5th Nov 20251:28 pmRNSHolding(s) in Company
23rd Oct 20257:00 amRNSTrading statement - Autumn 2025
14th Oct 20257:00 amRNSAppointment of joint corporate broker
4th Sep 20255:17 pmRNSHolding(s) in Company
11th Aug 20258:00 amRNSDirector/PDMR Shareholding
6th Aug 20259:45 amRNSDirector/PDMR Shareholding
5th Aug 202511:57 amRNSDirector/PDMR Shareholding
5th Aug 202511:00 amRNSDirectorate Change
5th Aug 20257:00 amRNSInterim results
4th Jul 20257:01 amRNSDirector/PDMR Shareholding
1st Jul 20257:00 amRNSCovenant update
30th Jun 20257:00 amRNSDirectorate Changes
27th Jun 20254:21 pmRNSHolding(s) in Company
2nd Jun 20257:00 amRNSDivestment of William Blythe completed
6th May 20257:00 amRNSDivestment of William Blythe
1st May 20254:18 pmRNSResults of AGM
1st May 20257:00 amRNSTrading Statement - Spring 2025
15th Apr 20253:00 pmRNSHolding(s) in Company
28th Mar 20257:30 amRNSDirector/PDMR Shareholding
27th Mar 20257:30 amRNSDirector/PDMR Shareholding
25th Mar 20254:23 pmRNSAnnual Report and Notice of AGM
25th Mar 202511:43 amRNSDirector/PDMR Shareholding
25th Mar 202511:41 amRNSDirector/PDMR Shareholding
24th Mar 20257:30 amRNSHolding(s) in Company
17th Mar 20259:00 amRNSDirector/PDMR Shareholding
17th Mar 20259:00 amRNSDirector/PDMR Shareholding
11th Mar 20257:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.